Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Published in Respiratory Medicine and

Journal Scan / Research · August 29, 2023

Prevalence of Symptoms ≤12 Months After Acute Illness Among Adults Based on COVID-19 Testing Status in the US

MMWR. Morbidity and Mortality Weekly Report

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Emmett Kistler MD

MMWR. Morbidity and Mortality Weekly Report

Prevalence of Symptoms ≤12 Months After Acute Illness, by COVID-19 Testing Status Among Adults - United States, December 2020-March 2023

MMWR Morb. Mortal. Wkly. Rep. 2023 Aug 11;72(32)859-865, JCC Montoy, J Ford, H Yu, M Gottlieb, D Morse, M Santangelo, KN O'Laughlin, K Schaeffer, P Logan, K Rising, MJ Hill, LE Wisk, W Salah, AH Idris, RM Huebinger, ES Spatz, RM Rodriguez, RE Klabbers, K Gatling, RC Wang, JG Elmore, SA McDonald, KA Stephens, RA Weinstein, AK Venkatesh, S Saydah

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

COVID-19

Prevalence of Symptoms ≤12 Months After Acute Illness Among Adults Based on COVID-19 Testing Status in the US

Additional Info

Prevalence of Symptoms ≤12 Months After Acute Illness, by COVID-19 Testing Status Among Adults - United States, December 2020-March 2023

Further Reading

Radiologic Identification of Patients With Asymptomatic Mycobacterium avium Complex Pulmonary Infections

Cytisinicline for Vaping Cessation in Adults Using Nicotine E-Cigarettes

Novel Definitions of Wellness and Distress Among Family Caregivers of Patients With Acute Cardiorespiratory Failure

Vaccine Effectiveness Against Long COVID in Children and Adolescents

Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement

Effect of Inhaled Treprostinil on Long-Term Survival in Patients With Pulmonary Hypertension Associated With ILD

Early Postnatal High-Dose Fat-Soluble Enteral Vitamin A Supplementation to Lower Risk for Moderate or Severe Bronchopulmonary Dysplasia or Death in Infants With Extremely Low Birthweight

Risk-Based Lung Cancer Screening Performance in a Universal Healthcare Setting

Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in the US Hospitals

Serum Cytokine Biosignatures for Identification of Tuberculosis Among HIV-Positive Inpatients

Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation

Recently Updated